SM
ARNA

Sabby Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Sabby Management’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-27,478
Closed -$1.12M – 298
2014
Q3 		$1.15K Buy
27,478
+15,696
+133% +$701K 0.04% 149
2014
Q2 		$690K Sell
11,782
-9,788
-45% -$616K 0.03% 175
2014
Q1 		$1.36M Buy
+21,570
New +$1.43M 0.08% 126

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Sabby Management's ARNA Position: Q4 2014 in Review

Sabby Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q4 2014, closing a stake of 27,478 shares — an estimated $1.12M sold.

Sabby Management first reported a position in ARNA in Q1 2014 and held it in 3 quarters. The position peaked at $1.36M in Q1 2014. 129 funds tracked by Wall St. Rank hold ARNA as of Q4 2014.

  • Sabby Management reported no remaining Arena Pharmaceuticals Inc position as of Q4 2014 after selling out during the quarter.
  • Sabby Management sold 27,478 Arena Pharmaceuticals Inc shares in Q4 2014, an estimated $1.12M.
  • Sabby Management first reported a position in Arena Pharmaceuticals Inc in Q1 2014 and held it in 3 quarters.
  • Sabby Management's Arena Pharmaceuticals Inc position peaked at $1.36M in Q1 2014.
  • 129 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q4 2014.

Based on Sabby Management's 13F filing for Q4 2014, filed 17 Feb 2015.